City of Hope Comprehensive Cancer Center
Beckman Research Institute
Duarte, CA
Filters
Accepting patients
Tumor-Agnostic Precision Immunooncology and Somatic Targeting Rational for You (TAPISTRY) Phase II Platform Trial
Learn more- Phase 2
Accepting patients
TRIDENT-1
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1)
Learn more- Tyrosine Kinase (TK) Inhibitor
- Phase 1/2
- Has results
All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.
Help me find trialsAccepting patients
VMD-928
An Open-Label, Multiple-Dose, Dose-Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of VMD-928 in Subjects With Solid Tumors or Lymphoma
Learn more- Tyrosine Kinase (TK) Inhibitor
- Phase 1
Filters
Save & Share
Advanced Filters
Trial Enrollment Status
Phase
Trial Type
Hide Treatments I've Had
This option allows you to hide trials that include all treatments that you have already received.